Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Obstructive Lung Diseases

Free Subscription Articles published in Respir Res Retrieve available abstracts of 231 articles: HTML format

Single Articles

April 2026
1. SEMENZATO U, Santello V, Fichera G, Previtero D, et al
   Quantitative computed tomography body composition analysis for risk stratification in bronchiectasis.
   Respir Res. 2026 Apr 17. doi: 10.1186/s12931-026-03670.
   PubMed    
   
   
   
2. MAHE J, Muller G, Roche N, Bourdin A, et al
   Increasing propellant gas emissions from pressurized metered-dose inhalers in obstructive lung diseases in France over 11 years.
   Respir Res. 2026;27:171.
   PubMed     Abstract available
   
   
   
3. NIU W, Huang J, Hu Y, Tang G, et al
   Short-term effects of air pollutants on asthma hospitalizations in a megacity in North China (2016-2021): a time-series study.
   Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03620.
   PubMed    
   
   
   
4. HUGO T, Harper AR, Leander J, Gardiner P, et al
   Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).
   Respir Res. 2026 Apr 14. doi: 10.1186/s12931-026-03613.
   PubMed    
   
   
   
5. FISCHER BC, Drick N, Liu B, Riemann L, et al
   B cell activating factor (BAFF) levels are associated with failed remission after 12 months of treatment with benralizumab and mepolizumab in severe asthma.
   Respir Res. 2026 Apr 2. doi: 10.1186/s12931-026-03500.
   PubMed    
   
   
   March 2026
6. LV R, Li Z, Zhao C, Wang M, et al
   B1 cells drive pulmonary emphysema progression through ADAM10.
   Respir Res. 2026 Mar 31. doi: 10.1186/s12931-026-03640.
   PubMed    
   
   
   
7. KO FWS, Chan KKP, Ng TCC, Lo RLP, et al
   A 3-year prospective study to assess clinical characteristics and risk factors for exacerbations in patients with asthma-COPD overlap based on the GINA guideline compared with patients with asthma and COPD.
   Respir Res. 2026 Mar 29. doi: 10.1186/s12931-026-03643.
   PubMed    
   
   
   
8. TANABE N, Sato A, Maetani T, Sakamoto R, et al
   A novel quantitative method for CT assessment of bronchiectasis using AI-based airway segmentation and upper limits of normal airway caliber.
   Respir Res. 2026 Mar 16. doi: 10.1186/s12931-026-03629.
   PubMed    
   
   
   
9. ZHANG M, Liu Q, Ju L, Zheng Y, et al
   Multi-omics integration identifies associations between large high-density lipoprotein and lung function, asthma, and COPD: evidence from genetic and population-based analyses.
   Respir Res. 2026 Mar 6. doi: 10.1186/s12931-026-03562.
   PubMed    
   
   
   
10. TUMMLER B, Schulz A, Minso R, Alfeis N, et al
    CFTR activity in nasal potential difference of adults with idiopathic bronchiectasis.
    Respir Res. 2026 Mar 3. doi: 10.1186/s12931-026-03599.
    PubMed    
    
    
    February 2026
11. GARCIA-RIVERO JL, Hannaoui Anaaoui A, Pallares-Sanmartin A, Blanco-Aparicio M, et al
    Multidomain clinical and biological remission with tezepelumab in severe asthma: a 12-month multicentre real-world study.
    Respir Res. 2026 Feb 27. doi: 10.1186/s12931-026-03597.
    PubMed    
    
    
    
12. GRAETER S, Gonzalez-Jaramillo N, Wildschut MHE, Capriotti L, et al
    Distinct pulmonary pathophysiological mechanisms in COPD, bronchiectasis, and primary immunodeficiency: a multi-omics investigation of disease heterogeneity via sputum and blood profiling.
    Respir Res. 2026 Feb 25. doi: 10.1186/s12931-025-03481.
    PubMed    
    
    
    
13. MOON SW, Kim M, Kim EY, Kang C, et al
    Longitudinal change of lung microbiome in chronic obstructive pulmonary disease: a prospective cohort study.
    Respir Res. 2026;27:152.
    PubMed     Abstract available
    
    
    
14. CADENAS-JIMENEZ I, Camps-Massa P, Goncalves-Carvalho F, Benaali-Bakkar Y, et al
    Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study.
    Respir Res. 2026;27:87.
    PubMed     Abstract available
    
    
    
15. CHEN Y, Shen Y, Shen H, Liu Z, et al
    GLP-1RAs: antidiabetic drug crossover-new hope for chronic inflammatory airway diseases.
    Respir Res. 2026;27:144.
    PubMed     Abstract available
    
    
    
16. SHAN X, Yan J, Han X, Zhu H, et al
    The association between long-term exposure to ozone and respiratory morbidity in Chinese adults: a nationwide cross-sectional study.
    Respir Res. 2026;27:138.
    PubMed     Abstract available
    
    
    
17. DEVILLIERS MA, Saber Cherif L, Brisebarre A, Chouquet R, et al
    Identification and validation of cilia-associated molecular candidates deregulated in severe asthma.
    Respir Res. 2026 Feb 9. doi: 10.1186/s12931-026-03548.
    PubMed    
    
    
    
18. XIAO Z, Shi Y, Zhao D, Wang Y, et al
    Triggering mechanisms of acute thunderstorm asthma: epithelial barrier disruption and immune dysregulation.
    Respir Res. 2026 Feb 7. doi: 10.1186/s12931-026-03532.
    PubMed     Abstract available
    
    
    
19. DABO AJ, Geraghty P, Evgrafov O, Campos M, et al
    CXCL11 levels regulate lung Treg responses to deter the onset of HIV-related COPD.
    Respir Res. 2026;27:121.
    PubMed     Abstract available
    
    
    
20. BOURDIN A, Canonica GW, Virchow JC, Borsos K, et al
    Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study.
    Respir Res. 2026 Feb 4. doi: 10.1186/s12931-026-03515.
    PubMed    
    
    
    January 2026
21. YAO L, Yuan X, Sun P, Fu H, et al
    Desmoglein-2 dysregulation impairs epithelial barrier integrity in eosinophilic asthma.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03510.
    PubMed    
    
    
    
22. AEGERTER H, Brightling CE, Dunican EM, Lambrecht BN, et al
    Effectiveness of biologics for reducing occlusive mucus plugs in patients with severe asthma: a systematic review.
    Respir Res. 2026 Jan 21. doi: 10.1186/s12931-026-03501.
    PubMed     Abstract available
    
    
    
23. WANG Y, Xu C, Zeng R, Liu X, et al
    CCN1 drives asthmatic airway remodeling through amplification of TGF-beta1/Smad3 signaling.
    Respir Res. 2026 Jan 20. doi: 10.1186/s12931-026-03506.
    PubMed    
    
    
    
24. LASSER C, Ax E, Weidner J, Winslow S, et al
    The involvement of Th17 inflammation and miR-363-3p in airway epithelial barrier dysfunction.
    Respir Res. 2026;27:30.
    PubMed     Abstract available
    
    
    
25. MA YC, Chen DL, Wu JH, Tang F, et al
    Runx2 acetylation enhances pulmonary inflammation in chronic obstructive pulmonary disease through activating CDK8.
    Respir Res. 2026;27:54.
    PubMed     Abstract available
    
    
    
26. RAITH J, Ruwisch J, Schupp JC, Graalmann T, et al
    Clinical implications of traction bronchiectasis in IPF and fibrotic RA-ILD - a retrospective single-center cohort study.
    Respir Res. 2026 Jan 13. doi: 10.1186/s12931-026-03497.
    PubMed     Abstract available
    
    
    
27. CARELLI M, Miotti J, Zanolin ME, Bilo MB, et al
    Mediterranean diet and asthma in adults: a multicentre case-control study in a general population sample.
    Respir Res. 2026 Jan 13. doi: 10.1186/s12931-025-03484.
    PubMed    
    
    
    
28. XU R, Li L, Shen Y, Tang X, et al
    A novel targeted lung denervation multi-polar radiofrequency ablation system for moderate to severe COPD patients: a translational study.
    Respir Res. 2026;27:50.
    PubMed     Abstract available
    
    
    
29. LI X, Zhang J, Feng Y, Zhou Q, et al
    Modulation of the NF-kappaB signaling pathway by the combined strategy of tocilizumab and dexamethasone for asthma therapy.
    Respir Res. 2026 Jan 8. doi: 10.1186/s12931-025-03458.
    PubMed     Abstract available
    
    
    
30. PANETTIERI RA JR, Mohan A, Lugogo NL, Ledford DK, et al
    Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study.
    Respir Res. 2026;27:5.
    PubMed     Abstract available
    
    
    
31. SHARMA R, Kelly RS, Mendez K, Chen Q, et al
    Differences in microRNA levels across metabo-endotypes reveal novel insights into asthma heterogeneity.
    Respir Res. 2026 Jan 7. doi: 10.1186/s12931-025-03452.
    PubMed    
    
    
    
32. YANG Q, Wang W, Zhu G, Xun H, et al
    GLCCI1 alleviates airway remodeling in asthmatic mice by inhibiting ZEB1-mediated epithelial-mesenchymal transition.
    Respir Res. 2026 Jan 7. doi: 10.1186/s12931-025-03476.
    PubMed    
    
    
    
33. HU H, Guo Z, Zhang J, Gao Y, et al
    Single-cell RNA sequencing elucidates potential mechanisms of endothelial cells in lung region-specific repair and remodeling in combined pulmonary fibrosis and emphysema.
    Respir Res. 2026 Jan 6. doi: 10.1186/s12931-025-03460.
    PubMed    
    
    
    December 2025
34. PIPARIA S, Kho AT, Desai B, Wong R, et al
    A principal component analysis-based endophenotype definition for change in lung function and inhaled corticosteroid treatment response in childhood asthma.
    Respir Res. 2025;26:351.
    PubMed     Abstract available
    
    
    
35. LEE SE, Kim BK, Kang N, Lee Y, et al
    Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry.
    Respir Res. 2025 Dec 27. doi: 10.1186/s12931-025-03451.
    PubMed     Abstract available
    
    
    
36. WANG K, Wu R, Fan M, Jia R, et al
    CPA3 drives the development of asthma by promoting the activation of the JAK/STAT6 pathway.
    Respir Res. 2025 Dec 23. doi: 10.1186/s12931-025-03456.
    PubMed    
    
    
    
37. DENG Y, Hall JK, Wang Y, Kim JH, et al
    Imaging the extracellular matrix structure and remodeling in healthy, fibrotic, and emphysematous human precision-cut lung slices.
    Respir Res. 2025 Dec 22. doi: 10.1186/s12931-025-03464.
    PubMed    
    
    
    
38. LARSSON C, Elowsson L, Tufvesson E, Cederberg A, et al
    Activation of regenerative pathways by exercise intervention in subjects with chronic obstructive pulmonary disease - a study protocol.
    Respir Res. 2025;27:16.
    PubMed     Abstract available
    
    
    
39. ZHANG H, Rao Z, Liu X, Shu Y, et al
    USP18 confers protection against allergic asthma by suppressing CCL8 production in alveolar type II epithelial cells.
    Respir Res. 2025 Dec 8. doi: 10.1186/s12931-025-03433.
    PubMed     Abstract available
    
    
    November 2025
40. TAO X, Xu X, Jiang X, Chen M, et al
    Susceptibility to childhood asthma modified by the interactive effects of polycyclic aromatic hydrocarbons exposure and genetic polymorphisms of the aryl hydrocarbon receptor signaling pathway: functional analysis based on lipid metabolism.
    Respir Res. 2025 Nov 28. doi: 10.1186/s12931-025-03428.
    PubMed     Abstract available
    
    
    
41. SUN Z, Li H, Zheng Y, Jia X, et al
    Interpretable machine learning model based on multimodal ultrasound for bedside diagnosis of acute exacerbations in COPD.
    Respir Res. 2025;26:338.
    PubMed     Abstract available
    
    
    
42. EMARA A, Awashra A, Ellebedy M, Abbas OF, et al
    Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials.
    Respir Res. 2025;26:332.
    PubMed     Abstract available
    
    
    
43. KE J, Lei S, He Z, Li Q, et al
    TIGIT/SHIP-1/RelB regulating Th1 inflammation in smoking induced COPD.
    Respir Res. 2025;26:325.
    PubMed     Abstract available
    
    
    
44. PILLAI S, Lawrence M, Zaldua JC, Hawkins K, et al
    Alterations in clot microstructure in acute exacerbations of COPD.
    Respir Res. 2025;26:323.
    PubMed     Abstract available
    
    
    
45. HOGER P, Benholz J, Weinheimer O, Wielputz MO, et al
    Quantitative analysis of chest computed tomography in alpha-1-antitrypsin deficiency.
    Respir Res. 2025;26:320.
    PubMed     Abstract available
    
    
    
46. BJORKLUND F, Palm A, Sundh J, Khor YH, et al
    Similar risk of hospitalization and mortality for patients continuing and discontinuing LTOT.
    Respir Res. 2025;26:321.
    PubMed     Abstract available
    
    
    
47. DIXON AE, Garrow OJ, Duchene B, Martin F, et al
    A randomized trial of continuous positive airway pressure for the asthma of obesity.
    Respir Res. 2025;26:314.
    PubMed    
    
    
    
48. ABUJABAL R, Alanta TM, Alhamidi RS, Altaie AM, et al
    IL-5 signaling in asthmatic derived fibroblasts exacerbates airway remodeling through ECM dysregulation and apoptosis resistance.
    Respir Res. 2025;26:307.
    PubMed     Abstract available
    
    
    
49. MARCON A, Martinelli L, Bansal AT, Berret E, et al
    Use of long-acting muscarinic antagonists for severe asthma: insights from clinicians in the SHARP network.
    Respir Res. 2025;26:306.
    PubMed     Abstract available
    
    
    October 2025
50. KELSEN SG, Maurer M, Waters M, Dash A, et al
    Safety and tolerability of astegolimab, an anti-ST2 monoclonal antibody: a narrative review.
    Respir Res. 2025;26:302.
    PubMed     Abstract available
    
    
    
51. SANTUS P, Oresta B, Finocchiaro D, De Rosa P, et al
    Modeled reductions in COPD exacerbation rates, mortality, and related medical costs due to increased SITT adoption: PROMETHEUS Italy.
    Respir Res. 2025;26:296.
    PubMed     Abstract available
    
    
    
52. GHOSH AJ, Chang KY, Moll M, Hess J, et al
    Genetic resilience to chronic obstructive pulmonary disease is a clinically distinct subtype in individuals with cigarette smoke exposure.
    Respir Res. 2025;26:297.
    PubMed     Abstract available
    
    
    
53. NOPSOPON T, Cabrera-Perez J, Lee PY, Brodeur KE, et al
    Impact of clinical factors and season on inflammatory cytokines in biologic-treated and untreated asthma.
    Respir Res. 2025;26:291.
    PubMed     Abstract available
    
    
    
54. CHENG WH, Chang WS, Feng PH, Chen KY, et al
    Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma.
    Respir Res. 2025;26:288.
    PubMed     Abstract available
    
    
    
55. FOO CT, Langton D, Donovan GM, Thompson BR, et al
    Bronchial thermoplasty reduces ventilation heterogeneity measured by phase-resolved functional lung magnetic resonance imaging in severe asthma.
    Respir Res. 2025;26:290.
    PubMed     Abstract available
    
    
    
56. LIN PY, Lee KY, Ho SC, Chuang HC, et al
    Oxidative stress triggers Itch-mediated TXNIP degradation and NF-kappaB activation promoting chronic obstructive pulmonary disease.
    Respir Res. 2025;26:286.
    PubMed     Abstract available
    
    
    September 2025
57. XIE C, Wang K, Yang K, Zhong Y, et al
    Toward precision medicine in COPD: phenotypes, endotypes, biomarkers, and treatable traits.
    Respir Res. 2025;26:274.
    PubMed     Abstract available
    
    
    
58. SIEVI NA, Schmidt F, Fricke K, Baur DM, et al
    Acute COPD exacerbation despite triple inhaled therapy: a molecular insight - TripleEx study.
    Respir Res. 2025;26:273.
    PubMed     Abstract available
    
    
    
59. EICHENLAUB M, Frye BC, Lehrmann H, Biertz F, et al
    ECG-based identification of COPD patients at risk for atrial fibrillation and its impact on adverse clinical outcomes-a subgroup analysis of the prospective multicenter COSYCONET cohort.
    Respir Res. 2025;26:272.
    PubMed     Abstract available
    
    
    August 2025
60. YUAN D, Yang X, He B, Han Y, et al
    Yanghe Pingchuan granules inhibit cellular senescence in airway smooth muscle cells to improve bronchial asthma via modulating Nrf2 acetylation.
    Respir Res. 2025;26:266.
    PubMed     Abstract available
    
    
    July 2025
61. FANG J, Wolters JC, Rafie K, Wang C, et al
    Extracellular vesicles from bronchoalveolar lavage fluid provide insights into the inhaled corticosteroids treatment response in COPD.
    Respir Res. 2025;26:254.
    PubMed     Abstract available
    
    
    
62. HOU D, Liu Z, Li X, Shen P, et al
    Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study.
    Respir Res. 2025;26:252.
    PubMed     Abstract available
    
    
    
63. TEJWANI V, Putcha N, Woo H, Liu C, et al
    Associations of serum and bronchoalveolar immunoglobulins with lung microbiota diversity, B-cell memory phenotypes, and COPD morbidity and exacerbations.
    Respir Res. 2025;26:250.
    PubMed     Abstract available
    
    
    
64. MOLL M, Hobbs BD, Pratte KA, Zhang C, et al
    Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency.
    Respir Res. 2025;26:247.
    PubMed     Abstract available
    
    
    
65. KUNTZMAN K, Hakansson KEJ, Ulrik CS, Rastogi D, et al
    Impact of natal and childhood metabolic markers on childhood asthma burden - a nationwide cohort study.
    Respir Res. 2025;26:246.
    PubMed     Abstract available
    
    
    
66. TEJWANI V, Wang Y, Tremblay LM, Azzato E, et al
    Increased exacerbations and hospitalizations among PI*MZ compared to PI*MM individuals: an electronic health record analysis.
    Respir Res. 2025;26:243.
    PubMed     Abstract available
    
    
    
67. LIU Q, Zhang Y, Duan R, Li W, et al
    Transcriptome reveals the landscape of alveolar macrophages exposed to combined hypoxia with cigarette smoke extract.
    Respir Res. 2025;26:241.
    PubMed     Abstract available
    
    
    
68. ZHANG J, Zhan Y, Deng Z, Chen S, et al
    MTMR14 depletion aggravates intrapulmonary inflammation and emphysema in experimental COPD through activating macrophage M1 polarization.
    Respir Res. 2025;26:238.
    PubMed     Abstract available
    
    
    
69. GUZMAN DE, Ruvuna L, Guo CJ, Sun Y, et al
    Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung Study.
    Respir Res. 2025;26:236.
    PubMed     Abstract available
    
    
    
70. WANG S, Kun T, Tian Z, Huang M, et al
    The MFGE8/integrin beta3 axis mitigates experimental neutrophilic asthma by suppressing NLRP3-Caspase-1 pathway-mediated NETosis.
    Respir Res. 2025;26:229.
    PubMed     Abstract available
    
    
    
71. KHALFAOUI L, Moore RM, Villasboas JC, Whitaker KR, et al
    Spatial phenotyping of human bronchial airways in obstructive lung disease.
    Respir Res. 2025;26:232.
    PubMed     Abstract available
    
    
    
72. DOSANJH DPS, Darrah E, Jensen TJ, Jevnikar Z, et al
    ARTEMISIA: a mechanistic study of a novel Janus kinase 1 inhibitor to advance molecular understanding and precision medicine in asthma.
    Respir Res. 2025;26:233.
    PubMed     Abstract available
    
    
    
73. RICHMOND BW, Lester MG, Lui V, Dusting J, et al
    X-ray velocimetry provides temporally and spatially-resolved biomarkers of lung ventilation in small airways disease.
    Respir Res. 2025;26:226.
    PubMed     Abstract available
    
    
    June 2025
74. WANG D, Liu C, Bao C, Hu J, et al
    Inhibition of the ATP synthase c subunit ameliorates HDM/LPS-induced inflammatory responses in asthmatic bronchial epithelial cells by blocking the mPTP-mtDNA-cGAS-STING axis.
    Respir Res. 2025;26:219.
    PubMed     Abstract available
    
    
    
75. DIALLO TD, Karrasch S, Jung M, Peters A, et al
    Paraspinal myosteatosis is associated with COPD: a cross-sectional MRI analysis from the population-based KORA cohort.
    Respir Res. 2025;26:217.
    PubMed     Abstract available
    
    
    
76. NJOROGE M, Pinheiro GP, Santana CVN, Ali H, et al
    Causes and MEchanisms foR non-atopic Asthma in Children (CAMERA) study: rationale and protocol.
    Respir Res. 2025;26:212.
    PubMed     Abstract available
    
    
    
77. TAYLOR SL, Brooks CR, Elms L, Manning SK, et al
    Sputum quality affects assessment of airway microbiology in childhood asthma.
    Respir Res. 2025;26:209.
    PubMed     Abstract available
    
    
    May 2025
78. TSCHENETT H, Vafai-Tabrizi F, Zwick RH, Valipour A, et al
    Digital mindfulness-based intervention for people with COPD - a multicentre pilot and feasibility RCT.
    Respir Res. 2025;26:199.
    PubMed     Abstract available
    
    
    
79. RUNOLD M, Karlsson I, Boren M
    FlexO2: A patient-controlled oxygen flow selector improving autonomy and daily function in long-term oxygen therapy (LTOT).
    Respir Res. 2025;26:200.
    PubMed     Abstract available
    
    
    
80. BELL AJ, Masotti M, Ram S, Pappas G, et al
    Use of quantitative CT chest imaging to derive and assess a radiographic phenotype of deployment-related constrictive bronchiolitis.
    Respir Res. 2025;26:195.
    PubMed     Abstract available
    
    
    
81. LI W, Yang Q, Chen Y, Sun Y, et al
    Angiotensin receptor blockers use and lung cancer risk in Chinese patients with chronic obstructive pulmonary disease: a population-based cohort study.
    Respir Res. 2025;26:186.
    PubMed     Abstract available
    
    
    
82. ZHAO L, Wu W, Chen G, Huang C, et al
    SERPINB10 promotes macrophage M2 polarization and airway inflammation in asthma.
    Respir Res. 2025;26:181.
    PubMed     Abstract available
    
    
    
83. SINGH D, Bafadhel M, Arya N, Marshall J, et al
    Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting beta(2)-agonist: post-hoc analyses of KRONOS.
    Respir Res. 2025;26:175.
    PubMed     Abstract available
    
    
    
84. TIAN J, Zhang Q, Peng M, Guo L, et al
    Exhaled volatile organic compounds as novel biomarkers for early detection of COPD, asthma, and PRISm: a cross-sectional study.
    Respir Res. 2025;26:173.
    PubMed     Abstract available
    
    
    April 2025
85. CARDENAS VJ JR, Seashore JB, Tapryal N, Ameri M, et al
    Low levels of DNA repair enzyme NEIL2 May exacerbate inflammation and genomic damage in subjects with stable COPD and during severe exacerbations.
    Respir Res. 2025;26:165.
    PubMed     Abstract available
    
    
    
86. ZHOU Y, Wu F, Deng Z, Wang Z, et al
    Lung function decline and incidence of chronic obstructive pulmonary disease in participants with spirometry-defined small airway dysfunction: a 15-year prospective cohort study in China.
    Respir Res. 2025;26:169.
    PubMed     Abstract available
    
    
    
87. LI B, Liu J, Cao Y, Wang Y, et al
    Multi-omics characterization of early chronic obstructive pulmonary disease.
    Respir Res. 2025;26:167.
    PubMed     Abstract available
    
    
    
88. JIANG H, Jiang Y, Dong R, Fu CY, et al
    ETS2 aggravate allergic airway inflammation by regulating ANT2-mediated cytosolic mitochondrial DsRNA levels.
    Respir Res. 2025;26:159.
    PubMed     Abstract available
    
    
    
89. FERREIRA DH, Ryan R, Smyth N, Clow A, et al
    The longitudinal impact of low-dose morphine on diurnal cortisol profiles in people with chronic breathlessness and chronic obstructive pulmonary disease (COPD): an exploratory study.
    Respir Res. 2025;26:156.
    PubMed     Abstract available
    
    
    
90. YI E, Li H, Liu Y, Li Q, et al
    An integrated machine learning model of transcriptomic genes in multi-center chronic obstructive pulmonary disease reveals the causal role of TIMP4 in airway epithelial cell.
    Respir Res. 2025;26:158.
    PubMed     Abstract available
    
    
    
91. ZHANG Y, Lang L, Guo X, Huang K, et al
    The association and impact of radiographic, pathological emphysema and spirometric airway obstruction on patients with resectable lung adenocarcinoma.
    Respir Res. 2025;26:151.
    PubMed     Abstract available
    
    
    
92. TERADA S, Tanabe N, Maetani T, Shiraishi Y, et al
    Antigravity muscle density on computed tomography and health-related independence in normal weight patients with chronic obstructive pulmonary disease.
    Respir Res. 2025;26:143.
    PubMed     Abstract available
    
    
    
93. PINKSTON RI, Schexnayder M, Perveen Z, Langohr IM, et al
    MMP12 deficiency attenuates menthol e-cigarette plus house dust-mite effects on pulmonary iron homeostasis and oxidative stress.
    Respir Res. 2025;26:135.
    PubMed     Abstract available
    
    
    
94. AHN SY, Ho TL, Ko EJ
    Evaluation of the influenza vaccine protection in the house dust mite-induced chronic allergic asthma mice model and the evaluation of squalene oil in water emulsion as an adjuvant candidate.
    Respir Res. 2025;26:132.
    PubMed     Abstract available
    
    
    
95. ZHANG J, Luo W, Cui Y, Sun B, et al
    B-cell epitope peptide immunotherapy alleviates chitin-binding protein-induced type 2 airway inflammation in a Blomia tropicalis-murine model.
    Respir Res. 2025;26:129.
    PubMed     Abstract available
    
    
    
96. CONLEY HE, Davis KU, Adler KB, Lavoie JP, et al
    MARCKS protein is a potential target in a naturally occurring equine model of neutrophilic asthma.
    Respir Res. 2025;26:126.
    PubMed     Abstract available
    
    
    
97. MOFFETT AT, Halpern SD, Weissman GE
    The effect of a post-bronchodilator FEV(1)/FVC < 0.7 on COPD diagnosis and treatment: a regression discontinuity design.
    Respir Res. 2025;26:122.
    PubMed     Abstract available
    
    
    March 2025
98. GOODALL E, Rothnie KJ, Numbere B, Zhang S, et al
    Describing the burden of moderate exacerbations in patients with asthma from the Extended Salford Lung Study (Ext-SLS): a retrospective cohort study.
    Respir Res. 2025;26:121.
    PubMed     Abstract available
    
    
    
99. KIM SH, Lee H, Kim MJ, Kim Y, et al
    Risk of acute exacerbation of chronic obstructive pulmonary disease after COVID-19 recovery: a nationwide population-based cohort study.
    Respir Res. 2025;26:116.
    PubMed     Abstract available
    
    
    
100. LIN Z, Liu S, Zhang K, Feng T, et al
     Molecular mechanisms and therapeutic targets of acute exacerbations of chronic obstructive pulmonary disease with Pseudomonas aeruginosa infection.
     Respir Res. 2025;26:115.
     PubMed     Abstract available
     
     
     
101. STAPLES KJ, Ackland J, Lukose S, Angermann B, et al
     Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD.
     Respir Res. 2025;26:114.
     PubMed     Abstract available
     
     
     
102. KIM JM, Hwang S, Cho HW, Kim Y, et al
     Two novel genetic variants in the WFDC2 gene from patients with bronchiectasis.
     Respir Res. 2025;26:108.
     PubMed     Abstract available
     
     
     
103. ADLER A, Bergwik J, Padra M, Papareddy P, et al
     Pharmacological inhibition of MutT homolog 1 (MTH1) in allergic airway inflammation as a novel treatment strategy.
     Respir Res. 2025;26:101.
     PubMed     Abstract available
     
     
     
104. GONG G, Shen S, Shen S, Wang R, et al
     YAP/TAZ-mediated nuclear membrane rupture in promoting senescence of skeletal muscle associated with COPD.
     Respir Res. 2025;26:98.
     PubMed     Abstract available
     
     
     
105. HUANG X, Qin H, Zhang R, Jia X, et al
     Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia.
     Respir Res. 2025;26:92.
     PubMed     Abstract available
     
     
     
106. SMITH C, Hasselgren M, Sandelowsky H, Stallberg B, et al
     Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study.
     Respir Res. 2025;26:84.
     PubMed     Abstract available
     
     
     February 2025
107. BERTOLINI F, Carriero VMA, Arrigo E, Guida G, et al
     Vascular remodeling and TSLP/angiogenin overexpression in severe mixed asthma.
     Respir Res. 2025;26:78.
     PubMed     Abstract available
     
     
     
108. ZHU W, Han L, He L, Peng W, et al
     Lsm2 is critical to club cell proliferation and its inhibition aggravates COPD progression.
     Respir Res. 2025;26:71.
     PubMed     Abstract available
     
     
     
109. WARDEN DE, Zhang H, Jiang Y, Arshad HS, et al
     The role of wheezing subtypes in the development of early childhood asthma.
     Respir Res. 2025;26:79.
     PubMed     Abstract available
     
     
     
110. LIN G, Wei Y, Guo Z, Wang H, et al
     Short- and long-term comparative effectiveness of nirmatrelvir/ritonavir and molnupiravir in asthma patients: a cohort study.
     Respir Res. 2025;26:75.
     PubMed     Abstract available
     
     
     
111. HUO Y, He S, Chen Y
     Lung organoids in COPD: recent advances and future prospects.
     Respir Res. 2025;26:76.
     PubMed     Abstract available
     
     
     
112. WANG Y, Xiao J, Yang X, Liu Y, et al
     Pulmonary microbiology and microbiota in adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.
     Respir Res. 2025;26:77.
     PubMed     Abstract available
     
     
     
113. LI N, Xu Y, Xiao X, Ding Z, et al
     Long-term trends in the burden of asthma in China: a joinpoint regression and age-period-cohort analysis based on the GBD 2021.
     Respir Res. 2025;26:56.
     PubMed     Abstract available
     
     
     
114. GUO Y, Zhou Y, Wang R, Lin Y, et al
     YAP as a potential therapeutic target for myofibroblast formation in asthma.
     Respir Res. 2025;26:51.
     PubMed     Abstract available
     
     
     
115. WANG Z, Zhao P, Yan G, Sun A, et al
     Neuropeptide S and its receptor aggravated asthma via TFEB dependent autophagy in bronchial epithelial cells.
     Respir Res. 2025;26:50.
     PubMed     Abstract available
     
     
     
116. BURNS AJ, Steinberg AW, Sargent JD, Ozga JE, et al
     Association of e-cigarette and cigarette use with self-reported chronic obstructive pulmonary disease (COPD): a multivariable analysis of a large United States data set.
     Respir Res. 2025;26:49.
     PubMed     Abstract available
     
     
     
117. LUO T, Ji W, Gong Y, Chen L, et al
     REDD1 mediates HDM-induced nuclear-cytoplasmic translocation and release of IL-33 in airway epithelial cells by downregulating Nrf2.
     Respir Res. 2025;26:47.
     PubMed     Abstract available
     
     
     January 2025
118. LI D, Shi X, Yang Y, Deng Y, et al
     Targeting BRD4 ameliorates experimental emphysema by disrupting super-enhancer in polarized alveolar macrophage.
     Respir Res. 2025;26:46.
     PubMed     Abstract available
     
     
     
119. GOPALAKRISHNAN V, Sparklin B, Kim JH, Bouquet J, et al
     NTHi killing activity is reduced in COPD patients and is associated with a differential microbiome.
     Respir Res. 2025;26:45.
     PubMed     Abstract available
     
     
     
120. DE VOLDER J, Bontinck A, Haelterman V, Boon L, et al
     Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution.
     Respir Res. 2025;26:43.
     PubMed     Abstract available
     
     
     
121. MOORE CM, Thornburg J, Secor EA, Hamlington KL, et al
     Comparative analysis of ambient, in-home, and personal exposures reveals associations between breathing zone pollutant levels and asthma exacerbations in high-risk children.
     Respir Res. 2025;26:40.
     PubMed     Abstract available
     
     
     
122. TIWARI A, Hobbs BD, Sharma R, Li J, et al
     Peripheral blood miRNAs are associated with airflow below threshold in children with asthma.
     Respir Res. 2025;26:38.
     PubMed     Abstract available
     
     
     
123. BOUYSSI A, Trecourt A, Demeautis T, Persat F, et al
     Aspergillus fumigatus is responsible for inflammation in a murine model of chronic obstructive pulmonary disease exacerbation.
     Respir Res. 2025;26:25.
     PubMed     Abstract available
     
     
     
124. DOMINGUEZ-DE-BARROS A, Perez-Rubio G, Fricke-Galindo I, Ramirez-Venegas A, et al
     Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.
     Respir Res. 2025;26:23.
     PubMed     Abstract available
     
     
     
125. CHEN X, Shang Y, Shen D, Shi S, et al
     Potential drug targets for asthma identified through mendelian randomization analysis.
     Respir Res. 2025;26:16.
     PubMed     Abstract available
     
     
     
126. PARK HS, Lee J, Kim H, Woo SD, et al
     Comparative analysis of real-world data on the efficacy and safety of and adherence to ICS/LABA combinations in asthma management.
     Respir Res. 2025;26:12.
     PubMed     Abstract available
     
     
     
127. ERIKSSON STROM J, Kebede Merid S, Linder R, Pourazar J, et al
     Airway MMP-12 and DNA methylation in COPD: an integrative approach.
     Respir Res. 2025;26:10.
     PubMed     Abstract available
     
     
     
128. WANG R, Li Y, Jiang Y, Liu X, et al
     Interaction study of the effects of environmental exposure and gene polymorphisms of inflammatory and immune-active factors on chronic obstructive pulmonary disease.
     Respir Res. 2025;26:5.
     PubMed     Abstract available
     
     
     
129. MISIUKIEWICZ-STEPIEN P, Zajusz-Zubek E, Gorska K, Krenke R, et al
     The different response of PM(2.5) stimulated nasal epithelial spheroids in control, asthma and COPD groups.
     Respir Res. 2025;26:8.
     PubMed     Abstract available
     
     
     
130. DITTRICH AS, De Pace CC, Brock JM, Trudzinski F, et al
     Outcome and safety 90 days after combined airway valve treatment of the right upper and middle lobes in patients with severe pulmonary emphysema.
     Respir Res. 2025;26:4.
     PubMed     Abstract available
     
     
     
131. WANG Z, Lin J, Liang L, Huang F, et al
     Global, regional, and national burden of chronic obstructive pulmonary disease and its attributable risk factors from 1990 to 2021: an analysis for the Global Burden of Disease Study 2021.
     Respir Res. 2025;26:2.
     PubMed     Abstract available
     
     
     December 2024
132. RODRIGUES G, Antao J, Deng Q, Baak BN, et al
     Trends in initial pharmacological COPD treatment in primary care (2010-2021): a population-based study using the PHARMO Data Network.
     Respir Res. 2024;25:447.
     PubMed     Abstract available
     
     
     
133. KIM E, Leem AY, Jung JY, Kim YS, et al
     Changes in muscle-to-fat ratio are associated with lung function decline and airflow obstruction in the general population.
     Respir Res. 2024;25:444.
     PubMed     Abstract available
     
     
     
134. TANG H, Li Z, Yang C, Fu L, et al
     CTSS contributes to airway neutrophilic inflammation in mixed granulocytic asthma.
     Respir Res. 2024;25:441.
     PubMed     Abstract available
     
     
     
135. HAEUSSLER K, Ismaila AS, Malmenas M, Noorduyn SG, et al
     Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.
     Respir Res. 2024;25:438.
     PubMed     Abstract available
     
     
     
136. KUNITOMO Y, Woo H, Balasubramanian A, Fawzy A, et al
     Longitudinal anemia status and risk for adverse outcomes in former smokers with COPD.
     Respir Res. 2024;25:437.
     PubMed     Abstract available
     
     
     
137. PENUELAS O, Del Campo-Albendea L, Morales-Quinteros L, Muriel A, et al
     A worldwide assessment of the mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Analysis of the VENTILAGROUP over time. A retrospective, multicenter study.
     Respir Res. 2024;25:434.
     PubMed     Abstract available
     
     
     
138. FENG H, Li Z, Zheng R
     Bexarotene ameliorated the pulmonary inflammation and M1 polarization of alveolar macrophages induced by cigarette smoke via PPARgamma/HO-1.
     Respir Res. 2024;25:431.
     PubMed     Abstract available
     
     
     
139. RAO X, Luo H, Luo K, Hu C, et al
     Silencing SMAD4 inhibits inflammation and ferroptosis in asthma by blocking the IL-17A signaling pathway.
     Respir Res. 2024;25:429.
     PubMed     Abstract available
     
     
     November 2024
140. KIM OH, Lee KN, Han K, Cho IY, et al
     Association between metabolic syndrome and chronic obstructive pulmonary disease development in young individuals: a nationwide cohort study.
     Respir Res. 2024;25:414.
     PubMed     Abstract available
     
     
     
141. FAN R, Qian H, Xu JY, Wang JY, et al
     Association of asthma and bronchiectasis: Mendelian randomization analyses and observational study.
     Respir Res. 2024;25:413.
     PubMed     Abstract available
     
     
     
142. XU Z, Li F, Xin Y, Wang Y, et al
     Prognostic risk prediction model for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD): a systematic review and meta-analysis.
     Respir Res. 2024;25:410.
     PubMed     Abstract available
     
     
     
143. NATH S, Qurashi H, Kitsios GD, Bain W, et al
     Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study.
     Respir Res. 2024;25:400.
     PubMed     Abstract available
     
     
     October 2024
144. AMBHORE NS, Balraj P, Kumar A, Reza MI, et al
     Kiss1 receptor knockout exacerbates airway hyperresponsiveness and remodeling in a mouse model of allergic asthma.
     Respir Res. 2024;25:387.
     PubMed     Abstract available
     
     
     
145. ZHANG J, Zhao D, Zhang L, Feng X, et al
     Impact of HHIP gene polymorphisms on phenotypes, serum IL-17 and IL-18 in COPD patients of the Chinese Han population.
     Respir Res. 2024;25:386.
     PubMed     Abstract available
     
     
     
146. SUN J, Tong X, Wang D, Wang L, et al
     Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study.
     Respir Res. 2024;25:385.
     PubMed     Abstract available
     
     
     
147. GOVONI M, Bassi M, Girardello L, Lucci G, et al
     CHF6523 data suggest that the phosphoinositide 3-kinase delta isoform is not a suitable target for the management of COPD.
     Respir Res. 2024;25:380.
     PubMed     Abstract available
     
     
     
148. LAI YT, Tsai YH, Hsieh MJ, Chen NH, et al
     Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO).
     Respir Res. 2024;25:377.
     PubMed     Abstract available
     
     
     
149. YAO LP, Wang ZK, Jiang XQ, Jiang B, et al
     MiR-1307-5p enhances fibroblast transdifferentiation to exacerbate chronic obstructive pulmonary disease through regulating FBXL16/HIF1alpha axis.
     Respir Res. 2024;25:376.
     PubMed     Abstract available
     
     
     
150. WATZ H, Kirsten AM, Ludwig-Sengpiel A, Krull M, et al
     Effects of inhaled beclometasone dipropionate/formoterol fumarate/glycopyrronium vs. beclometasone dipropionate/formoterol fumarate and placebo on lung hyperinflation and exercise endurance in chronic obstructive pulmonary disease: a randomised contro
     Respir Res. 2024;25:378.
     PubMed     Abstract available
     
     
     
151. MCDUFFIE EL, Panettieri RA Jr, Scott CP
     Correction to: G(12/13) signaling in asthma.
     Respir Res. 2024;25:371.
     PubMed    
     
     
     
152. LIU Y, Yin Q, Liu B, Lu Z, et al
     Fisetin reduces ovalbumin-triggered airway remodeling by preventing phenotypic switching of airway smooth muscle cells.
     Respir Res. 2024;25:370.
     PubMed     Abstract available
     
     
     
153. GOETEYN E, Taylor SL, Dicker A, Bolle L, et al
     Aggregatibacter is inversely associated with inflammatory mediators in sputa of patients with chronic airway diseases and reduces inflammation in vitro.
     Respir Res. 2024;25:368.
     PubMed     Abstract available
     
     
     
154. CAMINATI M, Vatrella A, Rogliani P, Carpagnano E, et al
     Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
     Respir Res. 2024;25:367.
     PubMed     Abstract available
     
     
     
155. DEAN J, Fowler SJ, Singh D, Beech A, et al
     Expiratory flow limitation development index (ELDI): a novel method of assessing respiratory mechanics in COPD.
     Respir Res. 2024;25:357.
     PubMed     Abstract available
     
     
     September 2024
156. TAO X, Xu Z, Tian H, He J, et al
     Differential proteins from EVs identification based on tandem mass tags analysis and effect of Treg-derived EVs on T-lymphocytes in COPD patients.
     Respir Res. 2024;25:349.
     PubMed     Abstract available
     
     
     
157. CAO W, Li J, Che L, Yang R, et al
     Single-cell transcriptomics reveals e-cigarette vapor-induced airway epithelial remodeling and injury.
     Respir Res. 2024;25:353.
     PubMed     Abstract available
     
     
     
158. EL ABD A, Dasari H, Dodin P, Trottier H, et al
     Associations between vitamin D status and biomarkers linked with inflammation in patients with asthma: a systematic review and meta-analysis of interventional and observational studies.
     Respir Res. 2024;25:344.
     PubMed     Abstract available
     
     
     
159. BONNESEN B, Eklof J, Biering-Sorensen T, Modin D, et al
     Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysis.
     Respir Res. 2024;25:339.
     PubMed     Abstract available
     
     
     
160. LU W, Aarsand R, Schotte K, Han J, et al
     Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary.
     Respir Res. 2024;25:338.
     PubMed     Abstract available
     
     
     
161. SAMORODNITSKY S, Kruk M, Lock EF, Kunisaki KM, et al
     Novel approach to exploring protease activity and targets in HIV-associated obstructive lung disease using combined proteomic-peptidomic analysis.
     Respir Res. 2024;25:337.
     PubMed     Abstract available
     
     
     
162. SHEN X, Liu H
     Using machine learning for early detection of chronic obstructive pulmonary disease: a narrative review.
     Respir Res. 2024;25:336.
     PubMed     Abstract available
     
     
     
163. KIM BG, Shin SH, Lee SK, Kim SH, et al
     Risk of incident chronic obstructive pulmonary disease during longitudinal follow-up in patients with nontuberculous mycobacterial pulmonary disease.
     Respir Res. 2024;25:333.
     PubMed     Abstract available
     
     
     
164. JI HW, Kang J, Kim HC, Jung J, et al
     The association between cumulative exposure to PM(2.5) and DNA methylation measured using methyl-capture sequencing among COPD patients.
     Respir Res. 2024;25:335.
     PubMed     Abstract available
     
     
     
165. ZHOU T, Guan Y, Lin X, Zhou X, et al
     CT-based whole lung radiomics nomogram for identification of PRISm from non-COPD subjects.
     Respir Res. 2024;25:329.
     PubMed     Abstract available
     
     
     August 2024
166. ZHANG D, Pu X, Zheng M, Li G, et al
     Employing a synergistic bioinformatics and machine learning framework to elucidate biomarkers associating asthma with pyrimidine metabolism genes.
     Respir Res. 2024;25:327.
     PubMed     Abstract available
     
     
     
167. TANG F, Liu HY, He QY, Liu Y, et al
     Cobalt exposure and pulmonary function reduction in chronic obstructive pulmonary disease patients: the mediating role of club cell secretory protein.
     Respir Res. 2024;25:324.
     PubMed     Abstract available
     
     
     
168. FAHERTY L, Zhang WZ, Salih MM, Robinson EK, et al
     Transcriptomic analysis reveals distinct effects of cigarette smoke on murine airspace and bone-marrow derived macrophages.
     Respir Res. 2024;25:322.
     PubMed     Abstract available
     
     
     
169. LEONHARDI J, Dahms U, Schnarkowski B, Struck MF, et al
     Impact of radiomics features, pulmonary emphysema score and muscle mass on the rate of pneumothorax and chest tube insertion in CT-guided lung biopsies.
     Respir Res. 2024;25:320.
     PubMed     Abstract available
     
     
     
170. WU Y, Xia S, Liang Z, Chen R, et al
     Artificial intelligence in COPD CT images: identification, staging, and quantitation.
     Respir Res. 2024;25:319.
     PubMed     Abstract available
     
     
     
171. ALLARD B, Ousova O, Savitskaya Z, Levardon H, et al
     Pulmonary adaptation to repeated poly(I:C) exposure is impaired in asthmatic mice: an observational study.
     Respir Res. 2024;25:314.
     PubMed     Abstract available
     
     
     
172. BARALDO S, Bonato M, Cassia S, Casolari P, et al
     Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
     Respir Res. 2024;25:315.
     PubMed     Abstract available
     
     
     
173. OUYANG S, Lu P, Li J, Jin H, et al
     Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation.
     Respir Res. 2024;25:311.
     PubMed     Abstract available
     
     
     
174. CHEN YF, Hou HH, Chien N, Lu KZ, et al
     The clinical impacts of lung microbiome in bronchiectasis with fixed airflow obstruction: a prospective cohort study.
     Respir Res. 2024;25:308.
     PubMed     Abstract available
     
     
     
175. GAO F, Lei J, Zhu H, Zhao L, et al
     Small airway dysfunction links asthma exacerbations with asthma control and health-related quality of life.
     Respir Res. 2024;25:306.
     PubMed     Abstract available
     
     
     
176. PATEL A, Buszkiewicz JH, Cook S, Arenberg DA, et al
     Longitudinal association of exclusive and dual use of cigarettes and cigars with asthma exacerbation among US adults: a cohort study.
     Respir Res. 2024;25:305.
     PubMed     Abstract available
     
     
     
177. SUGAWARA H, Saito A, Yokoyama S, Chiba H, et al
     Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry.
     Respir Res. 2024;25:300.
     PubMed     Abstract available
     
     
     
178. LIAO K, Wang F, Xia C, Xu Z, et al
     The cGAS-STING pathway in COPD: targeting its role and therapeutic potential.
     Respir Res. 2024;25:302.
     PubMed     Abstract available
     
     
     
179. MURO S, Kawayama T, Sugiura H, Seki M, et al
     Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history.
     Respir Res. 2024;25:297.
     PubMed     Abstract available
     
     
     
180. MCDUFFIE EL, Panettieri RA Jr, Scott CP
     G(12/13) signaling in asthma.
     Respir Res. 2024;25:295.
     PubMed     Abstract available
     
     
     
181. LIN S, Wang S, Jiang Q, Liu S, et al
     Exploring the mechanism of Lianhuaqingwen (LHQW) in treating chronic bronchitis based on network pharmacology and experimental validation.
     Respir Res. 2024;25:294.
     PubMed     Abstract available
     
     
     July 2024
182. GU W, Huang C, Chen G, Kong W, et al
     The role of extracellular traps released by neutrophils, eosinophils, and macrophages in asthma.
     Respir Res. 2024;25:290.
     PubMed     Abstract available
     
     
     
183. WAN M, Yu Q, Xu F, You LX, et al
     Novel hypoxia-induced HIF-1alphaactivation in asthma pathogenesis.
     Respir Res. 2024;25:287.
     PubMed     Abstract available
     
     
     
184. DUAN JL, Li CY, Jiang Y, Liu C, et al
     Microbiological characteristics of the lower airway in adults with bronchiectasis: a prospective cohort study.
     Respir Res. 2024;25:283.
     PubMed     Abstract available
     
     
     
185. MARTIN R, Nora M, Anna L, Olivia P, et al
     Altered hypoxia-induced cellular responses and inflammatory profile in lung fibroblasts from COPD patients compared to control subjects.
     Respir Res. 2024;25:282.
     PubMed     Abstract available
     
     
     
186. FRAJMAN A, Izhakian S, Mekiten O, Hadar O, et al
     Phenotypical characteristics of nontuberculous mycobacterial infection in patients with bronchiectasis.
     Respir Res. 2024;25:278.
     PubMed     Abstract available
     
     
     
187. TRUDZINSKI FC, Jorres RA, Alter P, Watz H, et al
     Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD).
     Respir Res. 2024;25:274.
     PubMed     Abstract available
     
     
     
188. VINCENT-GALTIE N, Marquant Q, Catherinot E, Ackermann F, et al
     Tezepelumab for refractory eosinophilic granulomatosis with polyangiitis-related asthma.
     Respir Res. 2024;25:272.
     PubMed     Abstract available
     
     
     
189. LIU X, Zhang J, Zhang D, Pan Y, et al
     Necroptosis plays a role in TL1A-induced airway inflammation and barrier damage in asthma.
     Respir Res. 2024;25:271.
     PubMed     Abstract available
     
     
     June 2024
190. HOCHHAUSEN N, Mechelinck M, Kroh A, Rossaint R, et al
     Chronic obstructive pulmonary disease affects outcome in surgical patients with perioperative organ injury: a retrospective cohort study in Germany.
     Respir Res. 2024;25:251.
     PubMed     Abstract available
     
     
     
191. OZALTIN B, Chapman R, Arfeen MQU, Fitzpatick N, et al
     Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
     Respir Res. 2024;25:249.
     PubMed     Abstract available
     
     
     
192. EKLOF J, Alispahic IA, Armbruster K, Lapperre TS, et al
     Systemic antibiotics for Pseudomonas aeruginosa infection in outpatients with non-hospitalised exacerbations of pre-existing lung diseases: a randomised clinical trial.
     Respir Res. 2024;25:236.
     PubMed     Abstract available
     
     
     
193. ZENG R, Zhang D, Zhang J, Pan Y, et al
     Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway.
     Respir Res. 2024;25:230.
     PubMed     Abstract available
     
     
     May 2024
194. PARK JE, Lee E, Singh D, Kim EK, et al
     The effect of inhaler prescription on the development of lung cancer in COPD: a nationwide population-based study.
     Respir Res. 2024;25:229.
     PubMed     Abstract available
     
     
     
195. ZHOU L, Roth M, Papakonstantinou E, Tamm M, et al
     Expression of glucocorticoid receptor and HDACs in airway smooth muscle cells is associated with response to steroids in COPD.
     Respir Res. 2024;25:227.
     PubMed     Abstract available
     
     
     
196. MONK PD, Brookes JL, Tear VJ, Batten TN, et al
     Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD.
     Respir Res. 2024;25:228.
     PubMed     Abstract available
     
     
     
197. XUE H, Lan X, Xue T, Tang X, et al
     PD-1(+) T lymphocyte proportions and hospitalized exacerbation of COPD: a prospective cohort study.
     Respir Res. 2024;25:218.
     PubMed     Abstract available
     
     
     
198. MOTTA H, Reuwsaat JCV, Lopes FC, Viezzer G, et al
     Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
     Respir Res. 2024;25:211.
     PubMed     Abstract available
     
     
     
199. FRANTZI N, Nguyen XP, Herr C, Alter P, et al
     Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort.
     Respir Res. 2024;25:207.
     PubMed     Abstract available
     
     
     
200. CADHAM CJ, Oh H, Han MK, Mannino D, et al
     The prevalence and mortality risks of PRISm and COPD in the United States from NHANES 2007-2012.
     Respir Res. 2024;25:208.
     PubMed     Abstract available
     
     
     
201. LAIMAN V, Chuang HC, Lo YC, Yuan TH, et al
     Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients.
     Respir Res. 2024;25:204.
     PubMed     Abstract available
     
     
     
202. AU-DOUNG PLW, Chan JCH, Kui OYH, Ho MKY, et al
     Objective monitoring tools for improved management of childhood asthma.
     Respir Res. 2024;25:194.
     PubMed     Abstract available
     
     
     April 2024
203. XU MM, Kang JY, Wang QY, Zuo X, et al
     Melatonin improves influenza virus infection-induced acute exacerbation of COPD by suppressing macrophage M1 polarization and apoptosis.
     Respir Res. 2024;25:186.
     PubMed     Abstract available
     
     
     
204. SHARMA E, Lauten K, Zebrak KA, Edwards KC, et al
     Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).
     Respir Res. 2024;25:185.
     PubMed     Abstract available
     
     
     
205. XIANG J, Liu B, Li Y, Ren Y, et al
     TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
     Respir Res. 2024;25:182.
     PubMed     Abstract available
     
     
     
206. FARINHA I, Heaney LG
     Barriers to clinical remission in severe asthma.
     Respir Res. 2024;25:178.
     PubMed     Abstract available
     
     
     
207. PINKERTON JW, Preite S, Piras A, Zervas D, et al
     PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
     Respir Res. 2024;25:175.
     PubMed     Abstract available
     
     
     
208. WAN R, Srikaram P, Xie S, Chen Q, et al
     PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
     Respir Res. 2024;25:174.
     PubMed     Abstract available
     
     
     
209. XIAO W, Chen YL, Du LY, Wu J, et al
     Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
     Respir Res. 2024;25:173.
     PubMed     Abstract available
     
     
     
210. LIU Y, Chen F, Zeng Z, Lei C, et al
     Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
     Respir Res. 2024;25:171.
     PubMed     Abstract available
     
     
     
211. ZHU Z, Zhao S, Li J, Wang Y, et al
     Development and application of a deep learning-based comprehensive early diagnostic model for chronic obstructive pulmonary disease.
     Respir Res. 2024;25:167.
     PubMed     Abstract available
     
     
     
212. GAO J, Yang Y, Xiang X, Zheng H, et al
     Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.
     Respir Res. 2024;25:165.
     PubMed     Abstract available
     
     
     
213. KOVACH MA, Kack U, Che KF, Brundin B, et al
     Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
     Respir Res. 2024;25:163.
     PubMed     Abstract available
     
     
     
214. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
     Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
     Respir Res. 2024;25:161.
     PubMed     Abstract available
     
     
     
215. DING Y, Wang Z, Zhang Z, You R, et al
     GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway.
     Respir Res. 2024;25:158.
     PubMed     Abstract available
     
     
     March 2024
216. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
     A novel quinoline with airway relaxant effects and anti-inflammatory properties.
     Respir Res. 2024;25:146.
     PubMed     Abstract available
     
     
     
217. KIM T, Shin SH, Kim H, Im Y, et al
     Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study.
     Respir Res. 2024;25:150.
     PubMed     Abstract available
     
     
     
218. DING H, Yan L, Wang Y, Lu Y, et al
     Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway.
     Respir Res. 2024;25:148.
     PubMed     Abstract available
     
     
     
219. LU L, Wu F, Peng J, Wu X, et al
     Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
     Respir Res. 2024;25:149.
     PubMed     Abstract available
     
     
     
220. WU J, Meng W, Ma Y, Zhao Z, et al
     Early smoking lead to worse prognosis of COPD patients: a real world study.
     Respir Res. 2024;25:140.
     PubMed     Abstract available
     
     
     
221. HSU YT, Wu CC, Wang CC, Sheu CC, et al
     Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
     Respir Res. 2024;25:139.
     PubMed     Abstract available
     
     
     
222. MEI S, Li D, Wang A, Zhu G, et al
     The role of sialidase Neu1 in respiratory diseases.
     Respir Res. 2024;25:134.
     PubMed     Abstract available
     
     
     
223. SHIN SH, Kim T, Kim H, Cho J, et al
     Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.
     Respir Res. 2024;25:133.
     PubMed     Abstract available
     
     
     
224. MCCLUSKEY ES, Liu N, Pandey A, Marchetti N, et al
     Quercetin improves epithelial regeneration from airway basal cells of COPD patients.
     Respir Res. 2024;25:120.
     PubMed     Abstract available
     
     
     
225. HONG X, Jiang M, Kho AT, Tiwari A, et al
     Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
     Respir Res. 2024;25:118.
     PubMed     Abstract available
     
     
     
226. CAI R, Gong X, Li X, Jiang Y, et al
     Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
     Respir Res. 2024;25:119.
     PubMed     Abstract available
     
     
     
227. LAN G, Xie M, Lan J, Huang Z, et al
     Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
     Respir Res. 2024;25:115.
     PubMed     Abstract available
     
     
     
228. WU Y, He B, Hua J, Hu W, et al
     Deciphering the molecular regulatory of RAB32/GPRC5A axis in chronic obstructive pulmonary disease.
     Respir Res. 2024;25:116.
     PubMed     Abstract available
     
     
     February 2024
229. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
     The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
     Respir Res. 2024;25:104.
     PubMed     Abstract available
     
     
     
230. BELL AJ, Pal R, Labaki WW, Hoff BA, et al
     Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
     Respir Res. 2024;25:106.
     PubMed     Abstract available
     
     
     
231. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
     Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
     Respir Res. 2024;25:99.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum